ApiJect
PrivateLast Round
Debt
Aug 27, 2024
Est. Valuation
$300M
Total Funding Raised
$763M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ApiJect is a healthcare technology company that produces cost-effective prefilled syringes using a single medical-grade plastic resin to enhance the availability of liquid medicines and vaccines while minimizing environmental impact.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Pharma Supply Chain, Smart Manufacturing
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ApiJect Comparables
Compare ApiJect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SiO2 Materials Science | 75% | |
| Credence MedSystems | 74% | |
| PharmaJet | 73% |
For institutional investors. Book with your work email.
ApiJect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 27, 2024 | ||||
| VC Round | May 18, 2022 | ||||
| Debt | Nov 19, 2020 | ||||
| Grant | May 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ApiJect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| U.S. Department of War | Grant |
| Trinity Capital | Debt |
| Royalty Pharma | VC Round |
| U.S. International Development Finance Corporation | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 46% MoM.
- Jan 16, 2026
Opened a 30,000 sq ft pharmaceutical manufacturing facility in Apex, NC.
For institutional investors. Book with your work email.
ApiJect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ApiJect's valuation, stock price, and market status.
Is ApiJect a public or private company?
ApiJect is a private company.
What is the current stock price of ApiJect?
ApiJect is a private company, so its shares have no public market price. Caplight tracks ApiJect's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ApiJect worth (valuation)?
ApiJect's valuation is estimated at $300.0M based on funding round data.
Can I buy ApiJect stock?
ApiJect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ApiJect's last funding round?
ApiJect's most recent funding round was Debt on August 27, 2024.
Who are the main investors in ApiJect?
Key investors in ApiJect include Trinity Capital, Royalty Pharma, U.S. International Development Finance Corporation.
Will ApiJect IPO soon?
No public IPO plans have been announced for ApiJect.
How can I track ApiJect secondary market activity?
Caplight tracks bids, offers, and trades in ApiJect's shares on secondary markets.